Hay K - Search Results

1

alpha2HS-glycoprotein, an antagonist of transforming growth factor beta in vivo, inhibits intestinal tumor progression.

Swallow CJ, Partridge EA, Macmillan JC, Tajirian T, DiGuglielmo GM, Hay K, Szweras M, Jahnen-Dechent W, Wrana JL, Redston M, Gallinger S, Dennis JW. Swallow CJ, et al. Among authors: hay k. Cancer Res. 2004 Sep 15;64(18):6402-9. doi: 10.1158/0008-5472.CAN-04-1117. Cancer Res. 2004. PMID: 15374947

2

Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.

Lal G, Ash C, Hay K, Redston M, Kwong E, Hancock B, Mak T, Kargman S, Evans JF, Gallinger S. Lal G, et al. Among authors: hay k. Cancer Res. 2001 Aug 15;61(16):6131-6. Cancer Res. 2001. PMID: 11507063

3

MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis.

Reitmair AH, Cai JC, Bjerknes M, Redston M, Cheng H, Pind MT, Hay K, Mitri A, Bapat BV, Mak TW, Gallinger S. Reitmair AH, et al. Among authors: hay k. Cancer Res. 1996 Jul 1;56(13):2922-6. Cancer Res. 1996. PMID: 8674041

4

Spontaneous intestinal carcinomas and skin neoplasms in Msh2-deficient mice.

Reitmair AH, Redston M, Cai JC, Chuang TC, Bjerknes M, Cheng H, Hay K, Gallinger S, Bapat B, Mak TW. Reitmair AH, et al. Among authors: hay k. Cancer Res. 1996 Aug 15;56(16):3842-9. Cancer Res. 1996. PMID: 8706033

5

Polyethylene glycol 8000 and colon carcinogenesis: inhibition in the F344 rat, promotion in the Min mouse.

Naigamwalla D, Chia MC, Tran TT, Medline A, Hay K, Gallinger S, Bruce WR. Naigamwalla D, et al. Among authors: hay k. Cancer Res. 2000 Dec 15;60(24):6856-8. Cancer Res. 2000. PMID: 11156379

6

Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons.

Smith AJ, Stern HS, Penner M, Hay K, Mitri A, Bapat BV, Gallinger S. Smith AJ, et al. Among authors: hay k. Cancer Res. 1994 Nov 1;54(21):5527-30. Cancer Res. 1994. PMID: 7923190

7

Comparative dual label study of first and second generation antitumor-associated glycoprotein-72 monoclonal antibodies in colorectal cancer patients.

Gallinger S, Reilly RM, Kirsh JC, Odze RD, Schmocker BJ, Hay K, Polihronis J, Damani MT, Shpitz B, Stern HS. Gallinger S, et al. Among authors: hay k. Cancer Res. 1993 Jan 15;53(2):271-8. Cancer Res. 1993. PMID: 8417820

8

Telomerase activity associated with acquisition of malignancy in human colorectal cancer.

Chadeneau C, Hay K, Hirte HW, Gallinger S, Bacchetti S. Chadeneau C, et al. Among authors: hay k. Cancer Res. 1995 Jun 15;55(12):2533-6. Cancer Res. 1995. PMID: 7780964

9

APC mutation and the crypt cycle in murine and human intestine.

Bjerknes M, Cheng H, Hay K, Gallinger S. Bjerknes M, et al. Among authors: hay k. Am J Pathol. 1997 Mar;150(3):833-9. Am J Pathol. 1997. PMID: 9060821 Free PMC article.

10

Radioimmunodetection of colorectal cancer metastases with 131I-labeled monoclonal antibody B72.3: a pilot study to determine efficacy of detection and pharmacokinetics.

Stern H, Reilly R, Gallinger S, Kirsh J, DeAngelis C, Papa M, Hay K, Polihronis J, Schmoker B. Stern H, et al. Among authors: hay k. Cancer Invest. 1993;11(2):129-34. doi: 10.3109/07357909309024830. Cancer Invest. 1993. PMID: 8462013

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

395 results

Search Page

Filters